feed,title,long_url,short_url
Benzinga,"Adalimumab, Infliximab and Etanercept Biosimilars Global Market to Reach $18.61 Billion by 2026 at a 40.6% CAGR",https://benzinga.com/pressreleases/22/11/n29894985/adalimumab-infliximab-and-etanercept-biosimilars-global-market-to-reach-18-61-billion-by-2026-at-a,
